Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.
Solmeyea has raised $3.3M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
Solmeyea's investors include EIC Accelerator, Circular Bio-based Europe Joint Undertaking.
Solmeyea is headquartered in Pallíni, Greece.
Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.
Solmeyea is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solmeyea — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/solmeyea. Accessed July 22, 2026.
VCBacked. (2025). Solmeyea — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/solmeyea
{{cite web |title=Solmeyea — Funding & Investors |url=https://www.vcbacked.co/company/solmeyea |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated